Compumedics (ASX:CMP) EV-to-EBIT : 13.43 (As of May. 17, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Compumedics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Compumedics's Enterprise Value is A$48.07 Mil. Compumedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.58 Mil. Therefore, Compumedics's EV-to-EBIT for today is 13.43.

The historical rank and industry rank for Compumedics's EV-to-EBIT or its related term are showing as below:

ASX:CMP' s EV-to-EBIT Range Over the Past 10 Years
Min: -30.05 Med: 18.55 Max: 80.07
Current: 13.44

During the past 13 years, the highest EV-to-EBIT of Compumedics was 80.07. The lowest was -30.05. And the median was 18.55.

ASX:CMP's EV-to-EBIT is ranked better than
66.96% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.385 vs ASX:CMP: 13.44

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Compumedics's Enterprise Value for the quarter that ended in Dec. 2023 was A$55.16 Mil. Compumedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.58 Mil. Compumedics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.49%.

Compumedics EV-to-EBIT Historical Data

The historical data trend for Compumedics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compumedics EV-to-EBIT Chart

Compumedics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

Get a 7-Day Free Trial

19.65

-10.28

62.41

12.73

-6.19

Compumedics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-	12.73	-	-6.19	-

Competitive Comparison of Compumedics's EV-to-EBIT

For the Medical Devices subindustry, Compumedics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compumedics's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Compumedics's EV-to-EBIT falls into.

Compumedics EV-to-EBIT Calculation

Compumedics's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	48.074	/	3.579
	=	13.43

Compumedics's current Enterprise Value is A$48.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Compumedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.58 Mil.

Compumedics (ASX:CMP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Compumedics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	3.579	/	55.16064
	=	6.49 %

Compumedics's Enterprise Value for the quarter that ended in Dec. 2023 was A$55.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Compumedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.58 Mil.

Compumedics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Compumedics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Compumedics (ASX:CMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Compumedics Ltd (ASX:CMP) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.compumedics.com.au

Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.